Dr. Tri Widiandani, S.Si.,Sp.FRS.,Apt

Profiles

• Profile Sinta
• Profile Scopus

Courses

Medicinal Chemistry, Physical Chemistry.

Research Interests

• Virtual modeling
• Synthesis of biologically active compounds
• Cancer targeted

Selected Publications

1. In silico study of phytochemicals contained in Brucea javanica in inhibiting the InhA enzyme as antituberculosis;Journal of Public Health in Africa;2023
2. In vivo anticancer activity of benzoxazine and aminomethyl compounds derived from eugenol;Journal of Public Health in Africa;2023;Antiviral and molecular docking analysis of methoxyflavones isolated from Melicope latifolia leaves against HCV;Journal of Research in Pharmacy;2023
3. In vitro study of pinostrobin propionate and pinostrobin butyrate: Cytotoxic activity against breast cancer cell T47D and its selectivity index;Journal of Public Health in Africa;2023
4. QSAR of Acyl pinostrobin derivatives as Anti-breast cancer against HER-2 receptor and their ADMET properties based on in silico Study;Q2 as Journal Research Journal of Pharmacy and Technology;2022
5. THE POTENCY OF 4-NITROBENZOYL-3-ALLYLTHIOUREA AS AN AGENT OF BREAST CANCER WITH EGFR/HER2: IN SILICO AND IN VITRO STUDY;Q2 as Journal Rasayan Journal of Chemistry;2022
6. Boesenbergia Pandurata as an Anti-Breast Cancer Agent: Molecular Docking and ADMET Study;Q3 as Journal Letters in Drug Design and Discovery;2022
7. Molecular modeling, admet prediction, synthesis and the cytotoxic activity from the novel n-(4-tert-butylphenylcarbamoyl) benzamide against hela;Q2 as Journal Rasayan Journal of Chemistry;2021
8. Phyllanthin and hypophyllanthin, the isolated compounds of Phyllanthus niruri inhibit protein receptor of corona virus (COVID-19) through in silico approach;Journal of Basic and Clinical Physiology and Pharmacology;2021
9. Thymoquinone and its derivatives against breast cancer with HER2 positive: In silico studies of ADMET, docking and QSPR;Journal of Basic and Clinical Physiology and Pharmacology;2021
10. Suko Hardjono, Tri Widiandani*, Bambang T. Purwanto, Anindi L. Nasyanka. 2019. Molecular Docking of N-benzoyl-N'-(4-fluorophenyl) thiourea Derivatives as Anticancer Drug Candidate and Their ADMET prediction. Research Journal of Pharmaceutical Technology. Volume 12(5): 2160-2166. DOI No: 10.5958/0974-360X.2019.00359.7. https://rjptonline.org/AbstractView.aspx?PID=2019-12-5-18 or https://www.researchgate.net/publication/330352887_Antiviral_activities_of_curcuma_genus_against_hepatitis_C_virus

     

11. Tutik Sri Wahyuni, Adita Ayu permatasari, Tri Widiandani, Achmad Fuada, Aty Widyawaruyantia, Chie Aoki-Utsubod and Hak Hotta. 2018. Antiviral activities of curcuma genus against hepatitis C virus. Natural Product Communications. Vol: 13, Issue: 12: 1579-1582. https://www.researchgate.net/publication/330352887_Antiviral_activities_of_curcuma_genus_against_hepatitis_C_virus

12. Tri Widiandani*, Siswandono, Edy Meiyanto, Melanny Ika Sulistyowaty, Bambang Tri Purwanto, Suko Hardjono. 2018. New N-Allylthiourea derivatives: Synthesis, molecular docking and in vitro cytotoxicity studies. Tropical Journal of Pharmaceutical Research. Vol 17 (8): 1607-1613. https://www.ajol.info/index.php/tjpr/article/view/178181

13. Siswandono, Tri Widiandani*, and Suko Hardjono. 2017. Docking and Cytotoxicity Test on Human Breast Cancer Cell Line (T47d) of N-(Allylcarbamothioyl)-3-chlorobenzamide and N-(Allylcarbamothioyl)-3, 4-dichlorobenzamide. Research Journal of Pharmaceutical, Biological and Chemical Sciences. Vol. 8(2)/[209), 1909-1914 https://www.researchgate.net/publication/317064889_Docking_and_Cytotoxicity_Test_on_Human_Breast_Cancer_Cell_Line_T47d_of_N-Allylcarbamothioyl-3-chlorobenzamide_and_N-Allylcarbamothioyl-3_4-dichlorobenzamide

14. Tri Widiandani*, Lusiana Arifianti, Siswandono. 2016. Docking, synthesis and cytotoxic activity test on human breast cancer cell line (t47d) of N-(allylcarbamothioyl)benzamide. International Journal of Pharmaceutical and Clinical Research 2016; 8(5)Suppl: 372-376. https://www.researchgate.net/publication/303787924_Docking_synthesis_and_cytotoxicity_test_on_human_breast_cancer_cell_line_T47D_of_N-Allylcarbamothioylbenzamide

15. Marcellino Rudyanto, Tri Widiandani, and Achmad Syahrani. 2016. 6-Allyl-3-(4-Methoxybenzyl-8-Methoxy-3, 4-Dihydro-2h-Benzo [E][1, 3] Oxazine and 4-Allyl-2-Methoxy-6-(4-Methoxybenzyl) Aminomethylphenol: Synthesis and Cytotoxicity Test on MCF-7 Cells. International Journal of Pharmaceutical and Clinical Research 2016; 8(5)Suppl: 387-391. https://www.researchgate.net/publication/303788180_6-Allyl-3-4-Methoxybenzyl-8-Methoxy-34-Dihydro-2h-Benzoe13Oxazine_and_4-Allyl-2-Methoxy-6-4-MethoxybenzylAminomethylphenol_Synthesis_and_cytotoxicity_test_on_MCF-7_cells

16. Marcellino Rudyanto, Tri Widiandani, Achmad Syahrani. 2015. Benzoxazine and Aminomethyl Derivatives of Eugenol: Cytotoxicity on MCF-7 Cell Line. Int. J. Pharm. Pharm. Sci. 7(5), 229-232. https://innovareacademics.in/journals/index.php/ijpps/article/view/4109

17. Sulistyowaty, M. I., Nofianti, K. A., Ekowati, J., Putra, G. S., Tri Widiandani, & Budiati, T. 2015. Antibacterial and Antioxidant Activity Evaluation of 1, 3-Diaryl-prop-2-en-1-one Derivatives. Procedia Chemistry, 16, 372-375. https://www.sciencedirect.com/science/article/pii/S1876619615002144

18. Marcellino Rudyanto, Juni Ekowati, Tri Widiandani, Toshio Honda. 2014. Synthesis and Brine Shrimp Lethality Test of Some Benzoxazine and Aminomethyl Derivatives of Eugenol. Int. J. Pharm. Pharm. Sci. 6(2), 96-98. https://www.semanticscholar.org/paper/SYNTHESIS-AND-BRINE-SHRIMP-LETHALITY-TEST-OF-SOME-Rudyanto-Ekowati/12f19c40655c258b147e20ae0c0f2c28c4bafc47

Contact

Dr. Tri Widiandani, S.Si.,Sp.FRS.,Apt

E-mail triwidiandani@yahoo.com

E-mail Instansi tri-w@ff.unair.ac.id